Moreover, the effect of Candesartan – ARB – was estimated by Fan et al. (88), enabling the attenuation of Ang II/AT1R/VEGF mediated angiogenesis, metastasis, and tumour growth in liver cancer at dose of 2 and 10 mg/kg/day (88). The gene discussed is AGTR1; the disease is liver cancer.